🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Allison LaHood

Harvard University

ORCID: 0000-0001-8415-133X

Also affiliated with Harvard Global Health Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan”.

Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan

Clinical Infectious Diseases(2024)10.1093/cid/ciae305

N/A

0.542DataRank · unranked

8 citations

Molly F. Franke, Letizia Trevisi, Gulzhanat Bekbolatova, Julia Shalimova, Gafurzhan Eshmetov +13 more

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications

The International Journal of Tuberculosis and Lung Disease(2023)10.5588/ijtld.22.0613

N/A

0DataRank · unranked

14 citations

Uzma Khan, Chao Zeng, Allison LaHood, Molly F. Franke, S Atwood +26 more

Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: A multicountry cohort study

medRxiv(2025)10.1101/2025.08.20.25334077

N/A

0DataRank · unranked

0 citations

Allison LaHood, Helen R. Stagg, Carole D. Mitnick, Letizia Trevisi, Cathy Hewison +18 more